SCHEMBL5077012

SCHEMBL5077012

COC=C(C(=O)O)c1ccccc1COc1cc(Cl)c(OCC(F)(F)F)c(Cl)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MRGPRX4 Q96LA9 5/20 0.38
HTT P42858 2/20 0.37
TP53 P04637 1/20 0.37
HIF1A Q16665 1/20 0.36
SLC16A3 O15427 1/20 0.36
SLC16A1 P53985 1/20 0.36
MCTS1 Q9ULC4 1/20 0.36
NR4A2 P43354 2/20 0.35
NPC1 O15118 1/20 0.35
RAB9A P51151 1/20 0.35
MEN1 O00255 1/20 0.35
S1PR2 O95136 1/20 0.35
S1PR4 O95977 1/20 0.35
LMNA P02545 1/20 0.35
GAA P10253 1/20 0.35
MAPT P10636 1/20 0.35
XBP1 P17861 1/20 0.35
KMT2A Q03164 1/20 0.35
PAX8 Q06710 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5077003 1.00 MRGPRX4 (0.38) MRGPRX4HTTTP53HIF1ASLC16A3
SCHEMBL5076975 0.91 TP53 (0.38) MRGPRX4HTTTP53HIF1ANR4A2
SCHEMBL5076982 0.91 TP53 (0.38) MRGPRX4HTTTP53HIF1ANR4A2
SCHEMBL5077009 0.91 MRGPRX4 (0.39) MRGPRX4HTTTP53HIF1ASLC16A3
SCHEMBL5079611 0.89 MRGPRX4 (0.39) MRGPRX4HTTTP53HIF1ANR4A2
SCHEMBL5079624 0.89 MRGPRX4 (0.39) MRGPRX4HTTTP53HIF1ANR4A2
SCHEMBL5075974 0.88 RAB9A (0.46) MRGPRX4HTTTP53HIF1ANR4A2
SCHEMBL5075979 0.88 RAB9A (0.46) MRGPRX4HTTTP53HIF1ANR4A2
SCHEMBL5079484 0.87 MRGPRX4 (0.44) MRGPRX4HTTTP53HIF1ANR4A2
SCHEMBL5079482 0.87 MRGPRX4 (0.44) MRGPRX4HTTTP53HIF1ANR4A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7435844-B2 Analogous compounds of strobilurines and their use as acaricides and insecticides ISAGRO RICERCA S.R.L. (IT) 2008-10-14 US disclosed
US-20060235075-A1 Analogous compounds of strobilurines and their use as acaricides and insecticides ISAGRO RICERCA S.R.L. (IT) 2006-10-19 US disclosed
EP-1494991-A1 ANALOGOUS COMPOUNDS OF STROBILURINES AND THEIR USE AS ACARICIDES AND INSECTICIDES Isagro Ricerca S.r.l. (IT) 2005-01-12 EP disclosed
WO-2003087032-A1 ANALOGOUS COMPOUNDS OF STROBILURINES AND THEIR USE AS ACARICIDES AND INSECTICIDES ISAGRO RICERCA S.R.L. (IT) 2003-10-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060235075-A1 Analogous compounds of strobilurines and their use as acaricides and insecticides DDT, RYR1, TPMT MRGPRX4 989/4885HTT 4420/4885TP53 2842/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.